This document lists the top 10 pharmaceutical mergers and acquisitions deals by deal value from 2008-2009. Roche acquired Genentech for $37.4 billion, the largest deal. Novartis acquired Alcon for $10.4 billion, while Takeda acquired Millennium Pharmaceuticals for $8.8 billion, which has closed. Teva Pharmaceutical acquired Barr Pharmaceuticals for $7.46 billion, and Eli Lilly acquired ImClone Systems for $6.5 billion, which has also closed.

1. Rank
Target Company or
Business Unit
Deal Value ($m) Acquiring Company
M&A Deal
Status
1 Genentech 43700 Roche Open
2 Alcon 10400 Novartis Open
3 Millennium Pharmaceuticals 8800
Takeda
Closed
4 Barr Pharmaceuticals 7460 Teva Pharmaceutical
Industries
Open
5 ImClone Systems 6500
Eli Lilly
Closed
6 Ranbaxy Laboratories 3950
Daiichi Sankyo
Open
7 Talecris Biotherapeutics 3100
CSL
Open
8 Zentiva 2590 Sanofi-Aventis Open
9 Alpharma 1600 King Pharmaceuticals Open
10 Sciele Pharma 1100 Shionogi Closed
Prepared By: ManasRanjanRout
Pharmaceutical & Healthcare Professional
New Delhi
Email: manasranjanrout4cv@gmail.com